Total Payments
$19,330
2024 Payments
$1,883
Companies
32
Transactions
861
Medicare Patients
2,371
Medicare Billing
$740,959
Payment Breakdown by Category
Food & Beverage$15,461 (80.0%)
Consulting$3,000 (15.5%)
Travel$601.13 (3.1%)
Education$256.64 (1.3%)
Gifts$10.81 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,461 | 844 | 80.0% |
| Consulting Fee | $3,000 | 1 | 15.5% |
| Travel and Lodging | $601.13 | 9 | 3.1% |
| Education | $256.64 | 6 | 1.3% |
| Gift | $10.81 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $4,717 | 58 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,495 | 146 | $0 (2024) |
| ABBVIE INC. | $1,332 | 94 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,330 | 67 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,211 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,108 | 58 | $0 (2024) |
| ITI, Inc. | $810.94 | 38 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $725.45 | 34 | $0 (2024) |
| Alkermes, Inc. | $710.52 | 32 | $0 (2024) |
| Allergan, Inc. | $705.55 | 51 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,883 | 92 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($344.41) |
| 2023 | $2,261 | 119 | ABBVIE INC. ($350.30) |
| 2022 | $1,999 | 115 | ABBVIE INC. ($455.78) |
| 2021 | $2,764 | 125 | Takeda Pharmaceuticals U.S.A., Inc. ($407.87) |
| 2020 | $1,753 | 101 | Otsuka America Pharmaceutical, Inc. ($293.60) |
| 2019 | $1,665 | 105 | Otsuka America Pharmaceutical, Inc. ($397.38) |
| 2018 | $5,398 | 108 | Neurocrine Biosciences, Inc. ($4,053) |
| 2017 | $1,607 | 96 | Otsuka America Pharmaceutical, Inc. ($455.93) |
All Payment Transactions
861 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: CNS | ||||||
| 08/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 491 | 1,978 | $361,740 | $167,318 |
| 2022 | 7 | 497 | 1,722 | $322,690 | $150,063 |
| 2021 | 8 | 649 | 2,884 | $486,050 | $228,974 |
| 2020 | 9 | 734 | 3,130 | $483,022 | $194,604 |
Total Patients
2,371
Total Services
9,714
Medicare Billing
$740,959
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 100 | 802 | $140,375 | $62,903 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 433 | $99,590 | $43,416 | 43.6% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 63 | 310 | $62,000 | $36,403 | 58.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 161 | 274 | $34,275 | $15,190 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 67 | $13,400 | $4,829 | 36.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 30 | 30 | $9,000 | $3,857 | 42.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 62 | $3,100 | $718.80 | 23.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 107 | 639 | $111,825 | $51,783 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 418 | $96,140 | $41,844 | 43.5% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 62 | 272 | $54,400 | $32,710 | 60.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 168 | 268 | $33,500 | $14,805 | 44.2% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 40 | 40 | $12,000 | $4,515 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 56 | $11,200 | $2,799 | 25.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 29 | $3,625 | $1,608 | 44.4% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 129 | 896 | $139,150 | $69,009 | 49.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 571 | $131,350 | $58,713 | 44.7% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 74 | 361 | $65,550 | $41,203 | 62.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 492 | $88,500 | $30,858 | 34.9% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 206 | 400 | $41,950 | $22,191 | 52.9% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 32 | 32 | $9,050 | $3,156 | 34.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 25 | 52 | $6,500 | $2,913 | 44.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 80 | $4,000 | $931.76 | 23.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 136 | 952 | $142,800 | $66,557 | 46.6% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 75 | 317 | $55,475 | $33,395 | 60.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 721 | $126,175 | $30,863 | 24.5% |
About Dr. Samir Farag, M.D
Dr. Samir Farag, M.D is a Psychiatry healthcare provider based in Collegeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285648329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samir Farag, M.D has received a total of $19,330 in payments from pharmaceutical and medical device companies, with $1,883 received in 2024. These payments were reported across 861 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($15,461).
As a Medicare-enrolled provider, Farag has provided services to 2,371 Medicare beneficiaries, totaling 9,714 services with total Medicare billing of $740,959. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Collegeville, PA
- Active Since 07/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285648329
Products in Payments
- INGREZZA (Drug) $4,717
- VRAYLAR (Drug) $2,028
- REXULTI (Drug) $1,891
- CAPLYTA (Drug) $1,155
- ABILIFY MAINTENA (Drug) $1,033
- INVEGA SUSTENNA (Drug) $959.07
- TRINTELLIX (Drug) $774.27
- Trintellix (Drug) $757.41
- HETLIOZ (Drug) $722.08
- LATUDA (Drug) $672.56
- ARISTADA (Drug) $579.19
- Equetro (Drug) $526.23
- NUEDEXTA (Drug) $361.34
- Fanapt (Drug) $287.53
- Auvelity (Drug) $286.09
- AUSTEDO (Drug) $281.54
- Austedo XR (Drug) $211.82
- FANAPT (Drug) $171.89
- VYVANSE (Drug) $159.52
- PERSERIS (Drug) $143.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Collegeville
M Ihtesham Janjua, Md, MD
Psychiatry — Payments: $5,215
Psychiatry $5,215
Dr. Christine Farag, Md, MD
Psychiatry — Payments: $382.01
Psychiatry $382.01
Dr. Ukpere Nimtor, Md; Msn, MD; MSN
Psychiatry — Payments: $79.03
Psychiatry $79.03
Dr. Sujana Kurri Yerram, M.d, M.D
Psychiatry — Payments: $77.68
Psychiatry $77.68